Skip to main content
. Author manuscript; available in PMC: 2011 Dec 9.
Published in final edited form as: J Med Genet. 2010 Nov 19;48(3):168–176. doi: 10.1136/jmg.2010.083022

Figure 1.

Figure 1

XP patients in study. A) Patient XP420BE complementation group XP-D at 9 months of age with severe blistering erythema of the malar area following minimal sun exposure. Note sparing of her forehead and eyes that were protected by a hat. B) Patient XP358BE (XP-C) at age 2 years did not sunburn easily but developed multiple hyperpigmented macules on her face. A rapidly growing SCC or keratoacanthoma grew on her upper lip and a pre-cancerous lesion appeared on her forehead. C) Northern African patient XP393BE (XP-C) [32] at age 23 years with numerous hyperpigmented macules on his face. Nodular basal cell cancer is present on his left nasal root. Pigmented basal cell cancer is present on his left cheek. His eyes show cornea scarring from unprotected sun exposure. D) Patient XP19BE (XP-A) [45] at age 35 years with neurological degeneration. He has numerous hyperpigmented macules on sun exposed areas of his face and neck. Progressive sensorineural deafness requires use of a hearing aid.